Urine Tests Could Be ‘Enormous Step’ in Diagnosing CancerMay 22, 2024Neuro-oncologyPediatricsBusiness of MedicineMixed Topics
Follow-Up Outcomes Data Often Missing for FDA Drug Approvals Based on Surrogate MarkersMay 20, 2024Business of MedicineMixed Topics
New mRNA Vaccines in Development for Cancer and InfectionsMay 10, 2024COVID-19 UpdatesMixed TopicsNeuro-oncologyPediatrics
Do Health-Related Social Needs Raise Mortality Risk in Cancer Survivors?May 7, 2024Mixed TopicsBusiness of MedicineNeuro-oncology
Most Targeted Cancer Drugs Lack Substantial Clinical BenefitApril 17, 2024Gene TherapyNeuro-oncologyPediatricsMixed TopicsBusiness of Medicine
Association Calls For Increased Oversight in Response to Reports of Possibly Counterfeit Botulinum ToxinApril 17, 2024Business of MedicineMixed Topics
CDC Investigating Adverse Events Related to Counterfeit, Mishandled Botulinum ToxinApril 16, 2024Mixed Topics
Oncologists Voice Ethical Concerns Over AI in Cancer CareApril 12, 2024Neuro-oncologyPediatricsMixed TopicsBusiness of Medicine
Less Than 50% of Accelerated Approvals Show Clinical BenefitApril 9, 2024Mixed TopicsNeuro-oncologyGene TherapyPediatrics
Should Opioids Be Used for Chronic Cancer Pain?April 5, 2024Fast Facts FridayNeuro-oncologyMixed TopicsPediatricsBusiness of MedicinePain
